Conquering Diseases

Study Of An Investigational Drug For Acute Myeloid Leukemia

Description

Seeking adults with Acute Myeloid Leukemia with an NPM1 mutation or KMT2A rearrangement for a study of an investigational drug to be used in combination with other chemotherapy drugs.

Overview

Newly diagnosed participants will get one of three different doses of the investigational drug. The drug will be given in 28-day cycles in combination with chemotherapy.

What we're hoping for

We are studying the safe dose of an investigational new drug to be used in combination with other chemotherapy drugs

Additional Information

ClinicalTrials.gov Identifier: NCT05735184

 Principal Investigator

Jan  Cerny, MD, PhD

UMass Memorial Health

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989